PharmSol Group is an integrated pharmaceutical services company, established in 2004 and headquartered in the United Arab Emirates. The company's slogan, "Enabling access to Pharma business across the Globe," reflects its mission to provide a full spectrum of pharmaceutical services to generic pharmaceutical companies worldwide. PharmSol offers solutions tailored to its clients' needs, including development, IPR, facility design, qualifications, audits, registrations, market access, and supply chain services, with a particular focus on EU and US regulatory compliance. With a localized presence in various geographies, PharmSol provides integrated solutions with a 'single window' access approach, ensuring seamless and timely delivery of services. The company's expertise in compliance and project management sets it apart in the industry. PharmSol not only conducts audits but also provides experts to manage compliance workloads, leading to successful audits by authorities such as USFDA, EU, and TGA. Despite the promising nature of PharmSol's business model and services, the information regarding its last investment and investors is currently unavailable. Nevertheless, PharmSol's commitment to addressing the needs of pharmaceutical companies on a global scale positions it as a significant player in the pharmaceutical industry. For more information, interested parties can visit the company's website at www.pharm-sol.com, and inquiries can be directed to [email protected].
There is no investment information
No recent news or press coverage available for PharmSol Group.